Autolus Therapeutics plc
AUTL
$2.03
-$0.08-3.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 74.27% | 7.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 74.27% | 7.94% | |||
| Cost of Revenue | 5.65% | -15.68% | |||
| Gross Profit | 86.31% | 34.80% | |||
| SG&A Expenses | 3.02% | -5.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.43% | -11.08% | |||
| Operating Income | 26.34% | 17.48% | |||
| Income Before Tax | 45.37% | 22.71% | |||
| Income Tax Expenses | -46.12% | 172.95% | |||
| Earnings from Continuing Operations | 45.37% | 20.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 45.37% | 20.74% | |||
| EBIT | 26.34% | 17.48% | |||
| EBITDA | 27.50% | 18.24% | |||
| EPS Basic | 45.39% | 20.74% | |||
| Normalized Basic EPS | 45.39% | 22.42% | |||
| EPS Diluted | 45.39% | 20.74% | |||
| Normalized Diluted EPS | 45.39% | 22.42% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||